Vimy Pharmaceuticals Inc.
StreetZero Signal 58
About Vimy Pharmaceuticals Inc.
Vimy Pharmaceuticals Inc. is a Canadian pharmaceutical company incorporated on July 19, 2024, under the Business Corporations Act (Ontario). It focuses on improving access to affordable medicines while supporting domestic pharmaceutical manufacturing capacity and long-term Canadian supply resilience. The company is advancing a portfolio of essential medicines as generic pharmaceutical products intended to support patients, healthcare systems, and Canada's life sciences sector.
LATEST FUNDINGPrivate Placement
$278K
Announced 2026-11-06
TOTAL RAISED$12M
IN THE NEWS
- 🔗 Vimy Pharmaceuticals Announces Closing of $12 Million Brokered Private Placement of Subscription Receipts, Filing of TSXV Listing Application and Execution of Definitive Agreement
- 🔗 Vimy Pharmaceuticals Announces Closing of $12 Million Brokered Private Placement of Subscription Receipts, Filing of TSXV Listing Application and Execution of Definitive Agreement
- 🔗 Vimy Pharma Partners with Wounded Warriors Canada, Pledges Portion of Profits to Support Veterans and First Responders
- 🔗 Vimy Pharma Partners with Wounded Warriors Canada, Pledges Portion of Profits to Support Veterans and First Responders
- 🔗 Vimy Pharmaceuticals Inc.
EMPLOYEES—
FOUNDED2024
HQToronto, Ontario, Canada
Industry
Pharmaceuticals
Tags
PharmaceuticalsGenericsCanada
Investors
Key highlights
- Incorporated July 19, 2024 in Ontario.
- Closed $12 million brokered private placement.
- Partners with Wounded Warriors Canada pledging portion of profits.
- Advancing portfolio of generic essential medicines.
Ask StreetZero about Vimy Pharmaceuticals Inc.
Put our AI to work on this deal.
Similar companies
Other Pharmaceuticals deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account